News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,899 Results
Type
Article (38830)
Company Profile (249)
Press Release (640820)
Section
Business (203595)
Career Advice (1979)
Deals (35349)
Drug Delivery (79)
Drug Development (80683)
Employer Resources (167)
FDA (16039)
Job Trends (14781)
News (343894)
Policy (32417)
Tag
Academia (2529)
Africa (712)
Alliances (48987)
Alzheimer's disease (1154)
Approvals (15973)
Arizona (175)
Artificial intelligence (76)
Asia (36848)
Australia (5996)
Bankruptcy (350)
Best Places to Work (11333)
Biosimilars (65)
Biotechnology (180)
Breast cancer (64)
C2C Services and Suppliers (78790)
California (2041)
Canada (983)
Cancer (567)
Career advice (1649)
Cell therapy (137)
China (163)
Clinical research (63405)
Collaboration (172)
Colorado (84)
Compensation (92)
Connecticut (84)
COVID-19 (2497)
Cystic fibrosis (78)
Data (447)
Diabetes (92)
Diagnostics (5991)
Drug pricing (70)
Earnings (83685)
Employer resources (142)
Europe (78775)
Events (107994)
Executive appointments (167)
FDA (16322)
Florida (294)
Funding (171)
Gene therapy (99)
GLP-1 (520)
Government (4300)
Healthcare (18616)
Hotbed/Location (480946)
Illinois (268)
Indiana (152)
Infectious disease (2532)
Inflammatory bowel disease (93)
Interviews (306)
IPO (16205)
Job creations (3618)
Job search strategy (1413)
Kansas (94)
Layoffs (396)
Legal (7833)
Lung cancer (119)
Manufacturing (99)
Maryland (423)
Massachusetts (1655)
Medical device (13060)
Medtech (13065)
Mergers & acquisitions (19034)
Metabolic disorders (269)
Michigan (127)
Minnesota (218)
Neuroscience (1332)
New Jersey (624)
New York (637)
NextGen Class of 2024 (6481)
Non-profit (4457)
North Carolina (599)
Northern California (892)
Obesity (163)
Ohio (111)
Opinion (172)
Patents (78)
Pennsylvania (613)
People (55894)
Phase I (19635)
Phase II (27909)
Phase III (20877)
Pipeline (127)
Postmarket research (2549)
Preclinical (8333)
Press Release (64)
Radiopharmaceuticals (230)
Rare diseases (150)
Real estate (5883)
Regulatory (21274)
Research institute (2305)
Resumes & cover letters (347)
South America (1089)
Southern California (829)
Startups (3559)
Texas (263)
United States (9124)
Vaccines (489)
Washington State (259)
Weight loss (135)
Date
Today (164)
Last 7 days (614)
Last 30 days (2568)
Last 365 days (36909)
2024 (27002)
2023 (40075)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
679,899 Results for "arcellx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Arcellx to Participate in Two Upcoming May 2024 Investor Conferences
Arcellx, Inc. announced that management will participate in two upcoming investor conferences.
May 7, 2024
·
2 min read
Business
Arcellx Provides First Quarter 2024 Financial Results
Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, reported business highlights and financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
5 min read
Biotech Bay
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Arcellx, Inc. and Kite, a Gilead Company, announced several key operational updates on their partnered anitocabtagene autoleucel multiple myeloma program.
May 9, 2024
·
9 min read
Biotech Bay
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Kite, a Gilead Company, and Arcellx, Inc. announced several key operational updates on their partnered anitocabtagene autoleucel multiple myeloma program.
May 9, 2024
·
9 min read
Biotech Bay
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, at 12:45 p.m. ET.
April 4, 2024
·
2 min read
Business
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Arcellx, Inc. (NASDAQ: ACLX) today reported business highlights and financial results for the fourth quarter and year ended December 31, 2023.
February 28, 2024
·
9 min read
Biotech Bay
Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference
Arcellx, Inc. (NASDAQ: ACLX) today announced that management will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference on Wednesday, March 6, at 2:50 p.m. ET.
February 29, 2024
·
2 min read
Biotech Bay
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference on Tuesday, March 26, at 1:00 p.m. ET.
March 20, 2024
·
2 min read
Business
Kite and Arcellx Announce Expansion in Strategic Partnership
Kite, a Gilead Company, and Arcellx, Inc., announced that the companies have expanded their existing collaboration, which was originally announced in December 2022.
November 15, 2023
·
11 min read
Business
Arcellx and Kite Announce Expansion in Strategic Partnership
Arcellx, Inc. and Kite, a Gilead Company, announced that the companies have expanded their existing collaboration, which was originally announced in December 2022.
November 15, 2023
·
11 min read
1 of 67,990
Next
